Cargando…
Effect of hydroxychloroquine on COVID-19 prevention in cancer patients undergoing treatment: study protocol for a randomized controlled trial
OBJECTIVES: In this study, we will investigate the effect of hydroxychloroquine on the prevention of novel coronavirus disease (COVID-19) in cancer patients being treated. TRIAL DESIGN: This is a two-arm, parallel-group, triple-blind, phase 2–3 randomized controlled trial. PARTICIPANTS: All patients...
Autores principales: | Rahimi, H., Allahyari, A., Ataei Azimi, S., Kamandi, M., Mozaheb, Z., Zemorshidi, F., Khadem-Rezaiyan, M., Bary, A., Seddigh-Shamsi, M., Nodeh, M. Moeini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131879/ https://www.ncbi.nlm.nih.gov/pubmed/34011413 http://dx.doi.org/10.1186/s13063-021-05292-8 |
Ejemplares similares
-
Effect of hydroxychloroquine on COVID-19 prevention in cancer patients undergoing treatment: a structured summary of a study protocol for a randomised controlled trial
por: Allahyari, Abolghasem, et al.
Publicado: (2020) -
Prognosis and complete remission rate of diffuse large B‐cell lymphoma patients in standard R‐CHOP with reduction of vincristine: A retrospective study
por: Riasi, Fatemeh, et al.
Publicado: (2023) -
Efficacy and safety of convalescent plasma therapy in severe COVID-19 patients with acute respiratory distress syndrome()
por: Allahyari, Abolghasem, et al.
Publicado: (2021) -
Prevalence of sexual dysfunction in HTLV-1 patients without spastic paraparesis and the association with psychiatric symptoms
por: Kamrani, Maedeh, et al.
Publicado: (2023) -
Proactive prophylaxis with azithromycin and hydroxychloroquine in hospitalized patients with COVID-19 (ProPAC-COVID): a statistical analysis plan
por: Sivapalan, Pradeesh, et al.
Publicado: (2020)